ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Price ControlSubscribe to Price Control

Drug Price Control in India

Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc­ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.

Prices of Patented Medicines in India

Medicines with valid patents generally enjoy exemption from price regulation in most countries. In India, the Drugs (Prices Control) Order lays down the rules for regulation of prices of medicines through a National List of Essential Medicines, inserted as Schedule-I of theDPCO. While any medicine that is included in Schedule-I automatically qualifies for price regulation, theDPCO exempts patented medicines that have been developed indigenously from price control for a period of five years.Can patented molecules for emerging as well as infectious diseases be brought under price regulation in India?

Sensible Drug Monitoring

WEEKLYECONOMIC AND POLITICAL Sensible Drug Monitoring The government has shown surprising sagacity in the formulation and announcement of the draft rules for the import and manufacture of new drugs for clinical trial or marketing. For the first time there appears to be some semblance of an organised effort towards a comprehensive

Back to Top